Serrapeptase is a protein-digesting enzyme that breaks down dead tissue, excess mucus, fibrin (the protein that forms blood clots), and inflammatory debris in the body. Originally isolated from bacteria found in the gut of silkworms, it’s now produced through fermentation and sold as a dietary supplement. Its effects span several areas: reducing inflammation and swelling, thinning mucus in the airways, disrupting bacterial biofilms, and supporting wound healing.
How Serrapeptase Works in the Body
Serrapeptase is a proteolytic enzyme, meaning it cuts apart proteins by breaking specific bonds between amino acids. What makes it unusual is its selectivity: it dissolves dead or damaged tissue, fibrin, mucus, and cellular debris while leaving living tissue intact. This selective action is what drives most of its therapeutic effects.
Because the enzyme is itself a protein, it’s vulnerable to stomach acid. Supplements need an enteric coating to survive the acidic environment of the stomach (around pH 1.2) and reach the small intestine intact. Without that coating, the enzyme unfolds and breaks apart before it can be absorbed. If you’re shopping for serrapeptase, enteric-coated tablets or capsules are essential for effectiveness.
Reducing Swelling After Surgery
The best-studied use of serrapeptase is controlling post-surgical inflammation. In a randomized clinical trial of 133 patients who had impacted wisdom teeth removed, those who took serrapeptase for five days had significantly less swelling and better jaw mobility compared to the placebo group. The improvement in jaw opening (trismus) was notable by the fourth day after surgery. Interestingly, the enzyme didn’t reduce pain scores compared to placebo, suggesting it targets the physical swelling component of inflammation rather than pain signaling directly.
A separate comparative study found that serrapeptase reduced jaw stiffness after tooth extraction more effectively than both corticosteroids and ibuprofen. This makes it particularly relevant for people who want to manage post-operative swelling without relying on steroids or anti-inflammatory drugs, though it works best alongside basic pain relief rather than as a replacement for it.
Thinning Mucus in Chronic Airway Disease
For people with chronic bronchitis or other airway conditions, thick, sticky mucus is a constant problem. Serrapeptase acts as a mucolytic, altering the structure of mucus so it becomes thinner and easier to clear.
In a four-week trial of patients with chronic airway disease, those taking 30 mg of serrapeptase daily saw meaningful improvements across multiple measures. Morning sputum weight dropped, the mucus became less viscous and less elastic, and the frequency of both coughing and expectoration decreased. The mucociliary transportability index, a measure of how efficiently the airways move mucus upward, nearly doubled: from 13.3 to 24.4. The enzyme also reduced the number of neutrophils (a type of white blood cell involved in inflammation) in the sputum, which likely contributed to the thinner consistency. For people dealing with productive coughs that won’t resolve, this is one of serrapeptase’s more practical applications.
Breaking Down Bacterial Biofilms
One of serrapeptase’s more intriguing properties is its ability to disrupt bacterial biofilms. Biofilms are slimy, protective structures that colonies of bacteria build around themselves, making infections harder to treat with antibiotics alone. Think of them as a shield that keeps drugs from reaching the bacteria inside.
Lab research on Staphylococcus aureus, including antibiotic-resistant MRSA, showed that serrapeptase inhibited biofilm formation by up to 88% in susceptible strains and 83% in MRSA. Under microscopy, treated MRSA colonies lost their organized architecture and were reduced to scattered, small clusters of cells. The enzyme also altered the bacterial cell wall composition, reducing key structural components and destabilizing the cells in ways similar to antibiotic damage.
The practical implication is that serrapeptase could make bacteria more vulnerable to antibiotics by stripping away their biofilm protection and forcing them into a free-floating state where drugs can reach them. This is still primarily laboratory evidence rather than proven clinical therapy, but it helps explain why some practitioners pair serrapeptase with antibiotic courses for stubborn infections.
Fibrin and Cardiovascular Effects
Serrapeptase dissolves fibrin, the fibrous protein that forms the structural basis of blood clots. It can also break down atherosclerotic plaque deposits, including fatty substances, cholesterol, and cellular waste that accumulate inside artery walls. This fibrinolytic activity is one reason the enzyme is sometimes marketed for cardiovascular support, though clinical evidence for preventing heart attacks or strokes in humans remains limited compared to its anti-inflammatory data.
Because it actively breaks down clotting proteins, serrapeptase can increase bleeding risk. If you take blood-thinning medications or have a bleeding disorder, this is a meaningful concern. The enzyme’s clot-dissolving action can compound the effects of anticoagulants and antiplatelet drugs.
Dosage and Supplement Forms
Serrapeptase dosages are measured in SPU (serrapeptase units) or sometimes listed in milligrams. A dose of 10,000 to 20,000 SPU equals roughly 5 to 10 mg. The typical adult dose used in studies is 10 mg taken three times daily, with a maximum of 60 mg per day (120,000 SPU). In Canada, where serrapeptase is regulated as a natural health product, products providing more than 60,000 units per day carry a recommendation to consult a health professional if used for longer than one week. At lower doses, the suggested limit before professional consultation is four weeks.
In the United States, serrapeptase is classified as a dietary supplement under a New Dietary Ingredient Notification. It is not FDA-approved as a drug, meaning manufacturers cannot make disease treatment claims. In Europe, it falls under Novel Food regulations and requires safety evaluation. These classifications mean the quality and potency of supplements can vary between brands, so choosing products from manufacturers that use third-party testing is worth the extra effort.
Side Effects and Safety Concerns
Most people tolerate serrapeptase well at standard doses. The most commonly reported side effects are digestive: nausea, stomach discomfort, and diarrhea. Rare but more serious reports include skin reactions and, in isolated cases, a type of lung inflammation called pneumonitis.
The most important safety consideration is its interaction with anything that affects blood clotting. Because serrapeptase dissolves fibrin and can thin the blood, combining it with anticoagulants, aspirin, or other antiplatelet supplements increases the risk of excessive bleeding. You should also stop taking it before any scheduled surgery, as impaired clotting during a procedure can cause complications. People who are pregnant or breastfeeding lack sufficient safety data to guide use.